Brief: Nextcell Pharma: ProTrans Stem Cells Approved For Clinical Trials On COVID-19 Patients

NextCell Pharma AB

21/10/2020 15:57

Oct 21 (Reuters) - NextCell Pharma AB  NXTCL.ST :
    * PROTRANS STEM CELLS APPROVED FOR CLINICAL TRIALS ON
COVID-19
PATIENTS
    * ANNOUNCES TODAY THAT APPLICATION FOR CLINICAL DRUG TESTING
OF
COVID-19 PATIENTS WITH DRUG CANDIDATE PROTRANS HAS BEEN APPROVED
BY BOTH SWEDISH ETHICS REVIEW AUTHORITY AND MEDICAL PRODUCTS
AGENCY
    * STUDY WILL BE CARRIED OUT AT THE UNIVERSITY HOSPITAL IN
ÖREBRO
IN COLLABORATION WITH DEPARTMENT OF CLINICAL TRIALS AND
KAROLINSKA TRIAL ALLIANCE

Source text for Eikon:  ID:nWkr2MZJ47 
Further company coverage:  NXTCL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))